← All medicines
Infutraze concentrate for solution for infusion
Licence PA2059/083/001 · Not marketed
- Licence holder
- Fresenius Kabi Deutschland GmbH (all products →)
- Active substances
- Copper chloride dihydrate, Manganese chloride tetrahydrate, Potassium iodide, Sodium selenite anhydrous, Zinc chloride
- Dosage form
- Concentrate for solution for infusion
- Route of administration
- Intravenous use
- ATC code
- B05XA31
- First authorised
- 30/06/2023
- Prescription status
- Product subject to prescription which may not be renewed (A)
- Supply
- Supply through pharmacies only
- Legal basis
- Well-established use application (Article 10a of Directive No 2001/83/EC)
Data: Health Products Regulatory Authority (HPRA) open dataset, licensed CC BY 4.0, published 04 Jul 2026. This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.